BRIMOCHOL PF eye drops; CARBACHOL PF eye drops; Brimonidine eye drops; Placebo for presbyopia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Mar 2025: Trial started, NCT06948357
  2. 29 Apr 2025: Trial registered, NCT06948357

The trials

NCT06948357: Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

State
Under way
Phase
Phase 2
People
119 planned
Started
24 Mar 2025
Primary completion
30 Sep 2025
Arms
Treatment Sequences 1, Treatment Sequences 2, Treatment Sequences 3, Treatment Sequences 4, Treatment Sequences 5, Treatment Sequences 6, Treatment Sequences 7
Results
None posted
  1. 24 Mar 2025: Trial started
  2. 29 Apr 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.